Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 27% ± 12% | |
| endothelial cell | 6 studies | 20% ± 4% | |
| glutamatergic neuron | 6 studies | 44% ± 21% | |
| epithelial cell | 5 studies | 26% ± 6% | |
| oligodendrocyte | 5 studies | 23% ± 5% | |
| GABAergic neuron | 4 studies | 46% ± 9% | |
| abnormal cell | 3 studies | 18% ± 3% | |
| interneuron | 3 studies | 53% ± 20% | |
| microglial cell | 3 studies | 19% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 30% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 39% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 2862.27 | 459 / 459 | 100% | 21.12 | 1118 / 1118 |
| esophagus | 100% | 3384.57 | 1445 / 1445 | 100% | 21.26 | 183 / 183 |
| pancreas | 100% | 1911.89 | 328 / 328 | 100% | 22.51 | 178 / 178 |
| prostate | 100% | 4101.35 | 245 / 245 | 100% | 26.69 | 502 / 502 |
| skin | 100% | 2996.68 | 1809 / 1809 | 100% | 23.58 | 472 / 472 |
| stomach | 100% | 2496.63 | 359 / 359 | 100% | 20.33 | 286 / 286 |
| thymus | 100% | 3648.00 | 653 / 653 | 100% | 21.74 | 605 / 605 |
| uterus | 100% | 3512.99 | 170 / 170 | 100% | 19.79 | 459 / 459 |
| intestine | 100% | 3945.96 | 966 / 966 | 100% | 22.96 | 526 / 527 |
| kidney | 100% | 3772.13 | 89 / 89 | 100% | 25.01 | 899 / 901 |
| lung | 100% | 2631.24 | 577 / 578 | 100% | 19.09 | 1154 / 1155 |
| brain | 100% | 3483.08 | 2635 / 2642 | 100% | 28.37 | 705 / 705 |
| bladder | 100% | 3607.33 | 21 / 21 | 100% | 20.33 | 502 / 504 |
| adrenal gland | 100% | 6000.57 | 258 / 258 | 100% | 35.37 | 229 / 230 |
| ovary | 100% | 3571.21 | 180 / 180 | 99% | 13.40 | 427 / 430 |
| liver | 100% | 2790.97 | 226 / 226 | 99% | 13.94 | 403 / 406 |
| adipose | 100% | 2856.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2945.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 20.32 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.72 | 29 / 29 |
| muscle | 100% | 3336.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3344.90 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.03 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.60 | 1 / 1 |
| heart | 99% | 2630.92 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 39% | 564.45 | 364 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0005525 | Molecular function | GTP binding |
| Gene name | URGCP |
| Protein name | Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein) Upregulator of cell proliferation |
| Synonyms | KIAA1507 URG4 |
| Description | FUNCTION: May be involved in cell cycle progression through the regulation of cyclin D1 expression. May participate in the development of hepatocellular carcinoma (HCC) by promoting hepatocellular growth and survival. May play an important role in development of gastric cancer. . |
| Accessions | ENST00000402306.7 [Q8TCY9-2] ENST00000455877.5 ENST00000453200.6 [Q8TCY9-1] C9JKA8 F8WDN0 ENST00000443736.5 [Q8TCY9-4] Q8TCY9 C9J0W2 F8WCC3 ENST00000446958.1 ENST00000439702.5 ENST00000336086.10 [Q8TCY9-4] ENST00000426198.5 |
